Skip to content

To observe the impact of lifestyle-based interventions (delivered digitally) on symptom relief and quality of life improvements for Indian IBS(irritable Bowel Syndrome) patients.

Digital Health Interventions for IBS- A longitudinal analysis of patient outcomes using an App (DailyBloomâ?¢ IBS) based approach - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/074762
Enrollment
500
Registered
2024-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Nil: Nil

Sponsors

Dr. Reddyâ??s Laboratories Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients from eighteen years of age to fifty years of age of either gender 2. Diagnosed with IBS (Using ROME III, ROME IV or Maningâ??s Criteria based on the treating physician discretion) 3. Ongoing medical treatment as per standard of care (SoC) under supervision of Gastroenterologist 4. Comfortable for using smartphone for management and agreeing to follow study related procedures 5. Subscribed to program -based management (Daily BloomTM IBS) pertaining to dietary, psychological and physical interventions 6. Provides written informed consent for participation in the study

Exclusion criteria

Exclusion criteria: 1. Patients with co-existing medically significant conditions affecting the participation as mentioned below: Patients with IBS who have alarm signs (haematochezia, melena, unintentional weight loss, older age of onset of symptoms, family history of IBD, colon cancer, or other significant GI disease. [IBS ACG Guideline]). 2. Patients with untreated/uncontrolled coexisting diseases (e.g. intestinal parasites, malignancy, psychiatric disorders, diabetes mellitus cardiovascular, pulmonary, hepatic, or renal disorder). 3. Patients with (irritable bowel syndrome on inflammatory bowel disease) IBD-IBS 4. In the opinion of the treating physician any other condition that may interfere the study participation

Design outcomes

Primary

MeasureTime frame
Effectiveness 1. To evaluate the change from the baseline in IBS-SSS score at each of the study specific time points 2. To evaluate the change from the baseline in IBS specific QoL score at each of the study specific time points 3. Hospital Anxiety and Depression Scale from baseline to week 14 Safety 1. Safety Monitoring Average number of flare-ups of the IBS symptoms during the study periodTimepoint: Baseline, Week 5, 11 & 14

Secondary

MeasureTime frame
Effectiveness Adherence will be based on the following 1.Nutritionists: No. of calls vs planned Duration of calls vs planned Food logging or planned 2.Psychological No of calls vs planned Duration of calls or planned Thought worksheets filled or number of flare ups reported 3.Videos No of videos watched or planned Total number of mins viewed or plannedTimepoint: Baseline, Week 5, 11 & 14

Countries

India

Contacts

Public ContactDr Sagar Katare

Dr. Reddyâ??s Laboratories Limited

sagarkatare@drreddys.com9223772427

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026